Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Wolf

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cutis|August 17, 2006
Safety and tolerability in the MORE trialJohn E Wolf
Advances in Therapy|August 31, 2002
Potential anti-inflammatory effects of topical retinoids and retinoid analoguesJohn E Wolf
Cutis|April 7, 2005
Present and future rosacea therapyJohn E Wolf
Cutis|February 13, 2004
The role of topical metronidazole in the treatment of rosaceaJohn E Wolf
Skinmed|January 16, 2004
Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherenceJohn E Wolf
Skinmed|September 13, 2018
Vaccines Hesitancy and the DermatologistPeter J Hotez, John E Wolf
International Journal of Dermatology|August 22, 2013
Understanding efficacy end-points in studies of field-directed therapy for actinic keratosisJohn E Wolf, Darrell S Rigel
Cutis|March 3, 2007
The CLEAR trial: results of a large community-based study of metronidazole gel in rosaceaJohn E Wolf, James Q Del Rosso
Cutis|May 19, 2006
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosaceaJohn E Wolf, Nabil Kerrouche, Stephanie Arsonnaud
Journal of Cutaneous Pathology|October 13, 2023
Perforating lichen nitidus in the setting of atopic dermatitisDavid Gustafson, John E Wolf, Laura Lester, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cutis|August 17, 2006
Safety and tolerability in the MORE trialJohn E Wolf
Advances in Therapy|August 31, 2002
Potential anti-inflammatory effects of topical retinoids and retinoid analoguesJohn E Wolf
Cutis|April 7, 2005
Present and future rosacea therapyJohn E Wolf
Cutis|February 13, 2004
The role of topical metronidazole in the treatment of rosaceaJohn E Wolf
Skinmed|January 16, 2004
Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherenceJohn E Wolf
Skinmed|September 13, 2018
Vaccines Hesitancy and the DermatologistPeter J Hotez, John E Wolf
International Journal of Dermatology|August 22, 2013
Understanding efficacy end-points in studies of field-directed therapy for actinic keratosisJohn E Wolf, Darrell S Rigel
Cutis|March 3, 2007
The CLEAR trial: results of a large community-based study of metronidazole gel in rosaceaJohn E Wolf, James Q Del Rosso
Cutis|May 19, 2006
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosaceaJohn E Wolf, Nabil Kerrouche, Stephanie Arsonnaud
Journal of Cutaneous Pathology|October 13, 2023
Perforating lichen nitidus in the setting of atopic dermatitisDavid Gustafson, John E Wolf, Laura Lester, et al.
Pageof 2